Protagonist Therapeutics Inc buy JPMorgan Chase & Co.
Start price
25.09.23
/
50%
€73.50
Target price
25.09.24
€32.11
Performance (%)
-
End price
26.09.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -0.676% | -0.676% | 237.156% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target lowered by analysts at JPMorgan Chase & Co. from $36.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.02.25
04.02.25
€51.09
04.02.26
04.02.26
45.54%
18.12.25
18.12.25
Stopped prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€70.20
07.11.26
07.11.26
6.52%
18.12.25
18.12.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.03.25
04.03.25
€54.07
04.03.26
04.03.26
45.54%
18.12.25
18.12.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
25.07.24
25.07.24
€44.18
25.07.25
25.07.25
-4.16%
26.07.25
26.07.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€73.50
28.02.24
28.02.24
€34.13
28.02.25
28.02.25
-
01.03.25
01.03.25

